Alarming update on incidence of Crimean-Congo hemorrhagic fever in Iraq in 2023

Zeenah Atwan1, Riyad Alhilfi2, Alaa K Mousa3

  • 1Central Laboratory, College of Medicine, University of Basrah, Basrah, Iraq & WHO Collaborating Centre for Public Health Education and Training, Imperial College London, UK.

IJID Regions
|January 4, 2024
PubMed

Insights

Crimean-Congo hemorrhagic fever (CCHF) cases surged in Iraq during 2023, with a 12.7% fatality rate. Regional variations and holiday surges highlight the need for targeted public health interventions to control this viral outbreak.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Crimean-Congo hemorrhagic fever (CCHF) outbreaks have been increasing in Iraq since 2021.
  • Lack of significant control measures has exacerbated the CCHF situation.
  • Awareness and intervention strategies are crucial for managing CCHF cases.

Purpose of the Study:

  • To analyze the epidemiological trends of CCHF in Iraq from January to August 2023.
  • To identify regional variations in CCHF case fatality rates (CFR).
  • To highlight factors contributing to CCHF outbreaks and inform public health strategies.

Main Methods:

  • Retrospective analysis of 1827 suspected CCHF cases from 18 provinces.
  • Confirmation of 511 CCHF cases using polymerase chain reaction (PCR).
  • Statistical analysis, including independent t-test, to compare CFR across provinces.

Main Results:

  • 511 out of 1827 suspected cases were confirmed positive for CCHF.
  • The overall case fatality rate (CFR) was 12.7%, with significant provincial variations (Erbil: 38.5%, Sulaimaniya/Anbar: 0%).
  • CCHF cases showed significant surges post-Iftar and Adha holidays, with higher CFR in provinces west and south of Baghdad.

Conclusions:

  • Provincial CFR disparities and holiday-related surges necessitate a unified public health intervention strategy.
  • Environmental factors like increased temperatures influencing tick vector behavior and uncontrolled animal movement are critical.
  • Further clinical and laboratory research is needed to understand virus or host determinants influencing CCHF mortality.
Abstract